ABT vs MMSI: fair value comparison
Abbott Laboratories and Merit Medical Systems, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, ABT currently sits closer to the top of our ranking by discount to fair value. MMSI carries the stronger quality grade.
| ABT | MMSI | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $99.60 | $89.20 |
| 12-month range | $82.56–$130.59 | $60.31–$93.18 |
| Rank by discount to fair value | #26 of 108 Healthcare | #30 of 108 Healthcare |
| Quality grade | B | A |
| Leverage | Moderate | Low |
| Margin trend | Expanding | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: ABT fair value analysis · MMSI fair value analysis